More extended indication of DAA therapy in patients with HCC, affordability, and further statistical considerations

J Hepatol. 2017 Sep 25:S0168-8278(17)32293-6. doi: 10.1016/j.jhep.2017.08.035. Online ahead of print.

Authors

Devi Tammineedi¹, Jacob Eisert², Johnson Ukken², Mary Froehlich², Mohamed Azab¹, Xibei Liu³, Ji Won Yoo⁴

Affiliations

¹ Department of Internal Medicine, University of Nevada Las Vegas School of Medicine, Las Vegas, NV, United States.
² University of Nevada Reno School of Medicine, Reno, NV, United States.
³ Department of Medicine, University of Arizona College of Medicine, Tucson, AZ, United States.
⁴ Department of Internal Medicine, University of Nevada Las Vegas School of Medicine, Las Vegas, NV, United States. Electronic address: [email protected].

PMID: 28958883
DOI: 10.1016/j.jhep.2017.08.035

No abstract available

Publication types

Letter